A detailed history of Sivik Global Healthcare LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Sivik Global Healthcare LLC holds 10,000 shares of ASND stock, worth $1.39 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$1.39 Million
% of portfolio
0.63%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$113.0 - $153.43 $1.13 Million - $1.53 Million
10,000 New
10,000 $1.49 Million

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.75B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.